Download Free Medical Pyelonephritis PowerPoint Presentation

Pyelonephritis PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Check out this medical PowerPoint presentation titled "Pyelonephritis”.

This medical PowerPoint presentation is about pyelonephritis, a type of urinary tract infection (UTI) that affects the kidneys. It occurs when bacteria, usually from the bladder, travel up the ureters (the tubes that connect the bladder to the kidneys) and infect one or both kidneys.

If left untreated, pyelonephritis can lead to serious complications such as sepsis (a life-threatening infection), kidney damage, and recurrent infections.

Treatment for pyelonephritis typically involves antibiotics to clear the infection, along with pain medication to relieve symptoms. In severe cases, hospitalization may be necessary for intravenous antibiotics and monitoring. Its important to seek medical attention promptly if you suspect you have pyelonephritis or any type of UTI.

Tags : Pyelonephritis, urinary tract infection, kidneys,Nephrology, Nephrology PowerPoint presentation

Published on : Jun 07, 2023 | Views : 972 | Downloads : 0

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

1 Pyelonephritis
Slide 2-

Definition It is Bacterial infection of the renal pelvis, tubules and interstitial tissue of one or both kidneys potentially organ- and/or life-threatening infection that characteristically causes some scarring of the kidney with each infection and may lead to significant damage to the kidney Pathophysiology and aetiology Infection usually ascends from the urethra most bacterial causes bowel organisms eg Ecoli (70-80%) Hospital-acquired infections may be due to coliforms and enterococci. Haematogenous spread is rare eg Staph aureus Frequently due to ureterovesical reflux 2
Slide 3-

3
Slide 4-

Complicated UTI Etiology Escherichia coli Klebsiella pneumoniae Enterobacter species Citrobacter species Proteus mirabilis Providencia species Pseudomonas aeruginosa Enterococci species (%) 21 – 54 1.9 – 17 1.9 – 9.6 4.7 – 6.1 0.9 – 9.6 18 2 – 19 6.1 – 23 4
Slide 5-

Microbiology of Community-Acquired Urinary Tract Infection Dysuria-Pyuria Sydrome in Females Other Community-Acquired Infection
Slide 6-

Microbiology of Nosocomial Acquired Urinary Tract Infection in Children or Adult Catheter-Associated Short-Term (< 30 –d) Catheterization Catheter-Associated Long-Term (> 30 –d) Catheterization
Slide 7-

Pyelonephritis may be acute or chronic Pathology Kidneys enlarge Interstitial infiltration of inflammatory cells Abscesses on the capsule and at corticomedullary junction Result in destruction of tubules and the glomeruli When chronic, kidneys become scarred, contracted and nonfunctioning 7
Slide 8-

Pathogenesis • Rectal and/or vaginal reservoirs • Colonization of perianal area • Bacterial migration to perivaginal area • Bacteria ascend through urethra to bladder • Intercourse may contribute urethral colonization and ascending infection • ASB in 1st trimester of pregnancy may cause pyelonephritis in 3rd trimester 8
Slide 9-

Symptoms develop rapidly (<24 hours) and may include: Acutely ill Chills Fever >38°C Flank pain and Nausea/vomiting Renal angle tenderness Confusion in elderly Leukocytosis Pyuria Bacteriuria In addition symptoms of lower tract involvement Dysuria Frequency 9 Clinical Manifestations of acute pyelonephritis
Slide 10-

Risk factors Mechanical: Structural abnormalities to the kidneys and the urinary tract vesicoureteral reflux (VUR) especially in young children, calculi urinary tract catheterisation nephrostomy pregnancy neurogenic bladder (e.g. due to spinal cord damage, spina bifida or multiple sclerosis) and prostate disease (e.g. benign prostatic hyperplasia) in men bladder tumours urethral strictures Constitutional: diabetes mellitus, immunocompromised states
Slide 11-

Diagnosis Is not always straightforward A number of studies using immunochemical markers have shown that many women, who initially present with lower tract symptoms, actually have pyelonephritis The extremes of age, the presentation may be so atypical (feeding difficulty or fever) In the elderly presentation may be mental status change or fever 11
Slide 12-

Laboratory Diagnosis of pyelonephritis Urinalysis 10 WBC/hpf is the usual upper limit of normal Positive result on leukocyte esterase dipstick test correlates well for detecting >10 WBC/hpf, with a specificity of 65%–95%, and sensitivity of 75%–95% Positive nitrate dipstick test result for bacteriuria is only moderately reliable; false-negative results are common Urine culture and sensitivity Blood culture 12
Slide 13-

Radiological investigations CT scan IVP=intra venous pyelogram Radionucleotide imaging with gallium citrate and indium-111-labeled WBCs 13
Slide 14-

Micturiting cystourethrogram (MCW showing bilateral VUR, grade IV on right and grade III on left-side. There is bilateral ureteral and pelvic dilation with blunting of fornices in the right kidney. 14
Slide 15-

Bilateral reflux extending into the pelvicalyceal systems of the kidney without dilatation of the calyces or ureters. (Note catheter in bladder) 15
Slide 16-

Medical Management Treated as outpatients if there is no nausea, vomiting or dehydration and other signs and symptoms of sepsis Very ill patients and all pregnant women are hospitalized at least for 2 to 3 days for parenteral therapy 2 weeks course Bactrim Ciprofloxacin Gentamicin with or without amoxicillin 16
Slide 17-

Problem Chronic or recurring symptomless infection persisting for months or years Another 6 weeks course if relapse Follow up urine culture 2 weeks after completion of therapy 17
Slide 18-

Chronic Pyelonephritis Repeated bouts of acute pyelonephritis may lead to chronic pyelonephritis Clinical manifestations No symptoms of infection unless an acute exacerbation occurs Fatigue Head ache Poor appetite Polyuria Excessive thirst Weight loss Progressive scarring  renal failure 18
Slide 19-

Assessment and diagnostic findings IVP Serum creatinine Blood urea Culture and sensitivity Complications ESRD=end stage renal disease Hypertension Kidney stones Medical management According to C&S result Drugs carefully titrated if renal function is impaired 19
Slide 20-

Nursing management Fluid balance – I / O chart Fluids encouraged unless contraindicated 4th hourly temp Antibiotics Bed rest Teach how to prevent recurrent infections : adequate fluids, emptying the bladder regularly and performing recommended perineal hygiene taking antibiotics as prescribed 20
Slide 21-

IDSA Treatment Guidelines:Acute Uncomplicated Pyelonephritis Mild or moderate symptoms:  Outpatient treatment (total of 7–14 days) oral treatment:  Fluoroquinolone  TMP/SMX, if uropathogen is known to be susceptible  If Gram-positive pathogen: amoxicillin or amoxicillin-clavulanate 21
Slide 22-

Treatment of Pyelonephritis Eradicate pathogens in kidney and urothelium, and treat/prevent bacteremia  Hospitalized patients: IV antibiotic first 48–72 hours followed by 7 days of oral antibiotic therapy Fluoroquinolone IV, then PO Aminoglycoside ± ampicillin IV, then TMP/SMX PO Third-generation cephalosporin IV, then TMP/SMX PO  Ambulatory patients: 7–14 days of PO therapy with one of the antimicrobials above 22
Slide 23-

Scarred and contorted kidneys 23
Slide 24-

Destruction of approximately 70% of the kidney. Numerous dilated calyces with yellow-brown calculi. The central necrotic areas are surrounded by dense fibrosis. 24
Slide 25-

Case 1 You are contacted by a FP resident regarding the use of a FQ in a 24 year old with an apparent UTI. She has complained of dysuria and frequency for the last 24 hours. Her UA is positive for bacteria using a nitrate dipstick and WBC’s using a dipstick esterase test. Her past medical history is significant for DM. She has no allergies and other than her diabetes there has been no other significant medical problems. 25
Slide 26-

Case 2 An asymptomatic 84 year old male with an indwelling foley catheter has a positive urine culture for P. aeruginosa. You have been contacted regarding the appropriate dose and interval for ciprofloxacin to begin therapy. 26
Slide 27-

Case 3 You have been consulted on a 72 year old female nursing home patient. She recently was treated for 10 days with ceftriaxone and azithromycin for presumed CAP. During her hospitalization a foley catheter was placed. She is currently afebrile and asymptomatic of any UTI symptoms but a culture of her urine at the end of her antibiotic therapy had a significant growth of yeast. How should she be managed? 27